Belviq Schedule

Belviq is a federally controlled substance because it can lead to abuse or drug dependence. In 2013, the Drug Enforcement Administration (DEA) classified Belviq as a Schedule IV drug under the Controlled Substances Act. You should never share this medication with another person Lorcaserin was approved by the Food and Drug Administration (FDA) on June 27, 2012, as an addition to a reduced-calorie diet and exercise, for chronic weight management and it will be marketed under the trade name BELVIQ®. Proposed Determination To Schedule Lorcaseri The recommended dose for BELVIQ XR is one 20 mg tablet administered orally once daily. Do not exceed recommended dose [ see Warnings and Precautions ( 5.4) ]. BELVIQ/BELVIQ XR can be taken with or without food. Swallow BELVIQ XR tablets whole and do not chew, crush, or divide. Response to therapy should be evaluated by week 12

At the time of marketing approval from BELVIQ, the FDA required Eisai to perform a long-term trial evaluating the cardiovascular effects associated with the use of the drug. The CAMELLIA-TIMI 61 trial for lorcaserin was a randomized, double-blind, placebo-controlled clinical trial to study approximately 12,000 men and women over five years with. Pursuant to 21 U.S.C. 811(a)(1), the Attorney General may, by rule, add to such a schedule or transfer between such schedules any drug or other substance if he (A) finds that such drug or other substance has a potential for abuse, and (B) makes with respect to such drug or other substance the findings prescribed by subsection (b) of section.

If you've been diagnosed with cancer after taking lorcaserin, contact our team today to schedule a free consultation. The Link Between Belviq and Cancer. The FDA recalled Belviq in February 2020 after discovering an association between the medication and cancer. The three types of cancer most closely linked to Belviq are pancreatic, lung, and. Belviq will be very accessible to patients as a schedule IV drug. The Drug Enforcement Agency, or DEA, is a branch of the U.S. Department of Justice. The Drug Enforcement Administration and the. Belviq (lorcaserin) is a prescription drug that helps overweight or obese people lose weight along with diet and exercise. Eisai Inc., the drug's maker, withdrew the product from the U.S. market in February 2020 after the U.S. Food and Drug Administration found an increased risk of cancer in clinical trials Lorcaserin is marketed under the brand name Belviq, developed by Arena pharmaceuticals. It is a weight loss drug that reduces appetite by activating a type of serotonin receptor known as the 5-HT2c receptor in a region of the brain called the hypothalamus, which is known to control appetite. Belviq is indicated as an adjunct to reduce calorie. Prescribing Qsymia® and Belviq® for Chronic Weight Management adopted August 15, 2013 Background Qsymia® (phentermine and topiramate extended-release) and Belviq® (lorcaserin hydrochloride) are FDA-approved Schedule IV medications. They are indicated as an adjunct to a reduced-calorie die

What schedule is belviq

Federal Register :: Schedules of Controlled Substances

  1. Belviq is an FDA-approved prescription weight-loss medication that when used with diet and exercise. This medication can help some adults living with extra weight, with a weight-related medical problem, or adults living with obesity, lose weight and keep it off
  2. BELVIQ/BELVIQ XR is listed in Schedule IV of the Controlled Substances Act. 9.2 Abuse In a human abuse potential study in recreational drug abusers, supratherapeutic oral doses of BELVIQ (40 and 60 mg) produced up to two- to six-fold increases on measures of High, Good Drug Effects, Hallucinations and Sedation compared.
  3. istration. The FDA requested the withdrawal after it reviewed Belviq safety data and found an increased occurrence of cancer in people who took the drug. The drug is no longer available in the United States

BELVIQ XR ® (lorcaserin hydrochloride) Extended-release Tablets. DESCRIPTION. BELVIQ XR (lorcaserin hydrochloride) extended-release tablets for oral use is a serotonin 2C receptor agonist for oral administration used for chronic weight management. Its chemical name is (R)-8-chloro-1-methyl2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate.The empirical formula is C 11 H 15 Cl 2 N. Some of the public comments posted about the DEA's proposed Belviq schedule are downright nutty. Log In Receive full access to our market insights, commentary, newsletters, breaking news alerts. Lorcaserin (Belviq) is a drug that promotes weight loss by affecting the brain's hypothalamus. People taking lorcaserin eat less and feel fuller. Side effects, drug interactions, and use during pregnancy should be reviewed prior to taking any medication

Lorcaserin hydrochloride is a hydrochloride obtained by reaction of lorcaserin with one equivalent of hydrochloric acid. Used as an anti-obesity drug. It has a role as a serotonergic agonist and an appetite depressant. It contains a lorcaserin (1+). Belviq is a DEA Schedule IV controlled substance 2021-07-14 - Lorcaserin is a prescription weight loss drug developed to treat obesity, approved by the Food & Drug Administration (FDA) in 2012, marketed under the brand name Belviq. Belviq was developed by Arena Pharmaceuticals. However, the rights to the drug were sold to the Japanese drugmaker, Eisai Inc., in 2017, and Eisai continued to manufacture the drug for U.S. consumption until the. Because Belviq has a potential for abuse (see below), the U.S. Drug Enforcement Administration must rule on how to schedule the drug. That process probably began no later than last May Belviq is a serotonergic drug. The development of a potentially life-threatening serotonin syndrome or Neuroleptic Malignant Syndrome (NMS)-like reactions have been reported during use of serotonergic drugs, including, but not limited to, selective serotonin-norepinephrine reuptake inhibitors (SNRIs) and selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs.

Belviq Has Been Removed From the Market

Belviq Dosage Guide - Drugs

Lorcaserin 1625 IV N Belviq Phenmetrazine 1631 II N Preludin SPA 1635 IV N 1-dimethylamino-1,2-diphenylethane, Lefetamine Phentermine 1640 IV N Ionamin, Fastin, Adipex-P, Obe-Nix, Zantryl Chlorphentermine 1645 III N Pre-Sate, Lucofen, Apsedon, Desopimon Clortermine 1647 III N Vorani Belviq, also known as lorcaserin, is a weight-loss drug that affects the signals in the brain that control appetite. Generally, this medication is used to treat obesity along with a change in diet in exercise in the consumers it is prescribed to. Belviq is strictly used to control appetite and does not work to control any other underlying. Based on these findings, Belviq should be placed into Schedule II of the CSA, which would prevent patients from receiving refills. One final note: Of the 22, there was actually what was almost a. The new obesity drug lorcaserin (Belviq, this came recently when the Drug Enforcement Agency deemed it was a schedule IV drug — the second-least-restrictive designation on a 5-step scale.. Belviq/Belviq XR s is a serotonin 2C receptor agonist-a substance that activates the serotonin receptors in the brain to create a feeling of satisfaction or fullness. It is indicated as a weight-loss medication that, when taken with regular diet and exercise, can help some adults living with extra weight, with a weight-related medical problem.


End Date. Meeting. Center. 08/03/2021 09:00 AM EDT. 08/03/2021 06:00 PM EDT. August 3, 2021: Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting Announcement - 08/03. Schedules often take the form of lists or descriptions of information. The following is an example of how you can reference a schedule in a definitive agreement: A true and complete list of the company's customers is set forth on Schedule [_] attached hereto. Exhibits. Exhibits are not considered to be part of the definitive agreement (PREA) to assess pharmacokinetic parameters related to Belviq dosing in pediatric patients ages 12 to 17 (inclusive). Data from this study should be considered when choosing dose(s) for the safety and efficacy study in this pediatric population. PMR/PMC Schedule Milestones: Final Protocol Submission: 03/31/2013 . Study/Trial Completion: 12/31/201 Lorcaserin is a weight loss drug, the first one to be approved since 1999. Its placement in Schedule IV indicates a low potential for abuse and low risk of dependence.. Other drugs in Schedule IV include benzodiazepines such as Xanax and Valium. Lorcaserin's trademark name will be Belviq

  1. NDA 208524 / BELVIQ XR (lorcaserin HCl) extended-release tablets p. 2 of 6 2. BACKGROUND Belviq (lorcaserin hydrochloride) was approved in the United States on 27 June 2012 (NDA 22529) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management i
  2. Belviq Oral tablet 10mg Drug Medication Dosage information. Learn about the reported side effects, related class drugs, and how these medications will affect your daily lifestyle. Visit cvs.com for more details
  3. istered with strong or moderate CYP2D6 inhibitors, reduce eliglustat dose from 84 mg BID to 84 mg once daily in extensive and intermediate metabolizers; eliglustat is contraindiated if strong or moderate CYP2D6 inhibitors are given concomitantly.

and Belviq ®. 3) Explain the requirements of pharmacists regarding the dispensing of controlled substances for . weight reduction. 4) Discuss patient cases regarding the dispensing of controlled substances for weight reduction. Pharmacists and Diet Drug Dispensing (OAC 4731-11-03 thru 4731-11-04 Belviq is listed as a Schedule ____. IV. What are the Primary Endpoints of all 3 studies? Weight loss at 1 year, which was assessed by: - percent of patients achieving greater than or equal to 5% weight loss, - percent of patients achieving greater than or equal to 10% weight loss Slim results. People who take the drug for a year can expect to lose just 3 to 3.7 percent of their weight, and may gain the weight back, research suggests. In one trial, patients taking Belviq. BELVIQ is a schedule IV controlled substances. What is the dosage of Belviq? Belviq is available as a 10 mg tablet. The recommended dose of Belviq is one 10 mg tablet twice a day by mouth with or without food. If the patient does not lose at least 5% of their initial body weight by week-12 discontinuation of treatment is recommended The findings were the result of a clinical trial assessing the safety of the drugs Belviq and Belviq RX, or lorcaserin, the FDA announced on Tuesday. At this time, the cause of the cancer is.

Belviq - Parrish DeVaugh

  1. imized by adhering to the recommended dosing schedule and avoiding coad
  2. Belviq oral. Show ratings & reviews for. All Conditions (174 reviews) Adjunct Treatment of Obesity in a Comprehensive Weight Reduction Regimen (102 reviews) Weight Loss Management for an Obese.
  3. BELVIQ XR is a prescription medicine that may help some obese adults or overweight adults who also have weight related medical problems lose weight and keep the weight off. BELVIQ XR should be used with a reduced calorie diet and increased physical activity
  4. BELVIQ is a schedule IV . FDA approved drug is be available in U.S. pharmacies only with a prescription. Patients are cautioned not to buy BELVIQ from parties offering BELVIQ without a valid prescription from their doctor. Eisai will market and distribute BELVIQ in the United States and Arena Pharmaceuticals will manufacture and supply the.
  5. Recently, the FDA made the public aware that a weight-loss drug known as Belviq was reported to have a link to multiple different cancers ranging from lung cancer to pancreatic cancer. While the FDA has made it clear that there is an increased risk of developing cancer with long term use of the drug, they are currently not suggesting a special cancer screening for those who have taken it

Belviq XR Oral tablet, extended release 20mg Drug Medication Dosage information. Learn about the reported side effects, related class drugs, and how these medications will affect your daily lifestyle. Visit cvs.com for more details Belviq is listed in Schedule IV of the Controlled Substances Act. Abuse. In a human abuse potential study in recreational drug abusers, supratherapeutic oral doses of lorcaserin (40 and 60 mg) produced up to two- to six-fold increases on measures of High, Good Drug Effects, Hallucinations and Sedation compared to placebo Not everyone responds to Belviq, you are the first I've heard of that has not responded. What you might try and will soon be recommended for people that do not respond is a combination of Belviq and phentermine. You are taking the 2 tablets a day of the Belviq about 12 hrs apart if possible? Well I hope you find something that helps you Belviq Lawsuit. Belviq, the brand name of lorcaserin, is a weight loss drug that originally hit the market in 2012. It was developed by Arena Pharmaceuticals and marketed by Eisai Corp, Ltd. However, it was voluntarily withdrawn from the market in February 2020 at the request of the FDA due to its risk of causing cancer Lorcaserin hydrochloride hemihydrate is a hydrate that is the hemihydrate form of lorcaserin hydrochloride. Used as an anti-obesity drug. It has a role as an appetite depressant and a serotonergic agonist. It contains a lorcaserin hydrochloride. Belviq is a DEA Schedule IV controlled substance

Qsymia Vs Contrave — INTERESTED? Locate a Doctor Near You

Belviq, once a popular weight loss drug, was used to reduce the urge to eat. It was a prescription-only medication and was approved for use by the Food and Drug Administration (FDA) in 2012. Schedule Your Free, No Cost, No Obligation Consultation Today. contact a lawyer today (973) 784-8583. 189 Franklin Avenue, Suite 1. Nutley, NJ 07110. Belviq is listed in Schedule IV of the Controlled Substances Act. Abuse. In a human abuse potential study in recreational drug abusers, supratherapeutic oral doses of lorcaserin (40 and 60 mg) produced up to two- to six-fold increases on measures of High, Good Drug Effects Belviq and its extended formula Belviq XR is prescribed for weight-loss in adults with weight-related medical conditions. The drugs are manufactured by Japanese company Eisai Inc. Belviq is known as a selective serotonin 2C receptor agonist, which means it activates very specific parts of your brain that make you feel full Schedule I (Xyrem or sodium oxybate is Schedule III) Heroin (no brand) Schedule I. lysergic acid diethylamide. LSD Schedule I. Magic Mushrooms. Psilocybin Schedule I. Mescaline. Belviq C-IV. Modafinil. Provigil C-IV. Pemoline. Cylert, Tradon C-IV. Pentazocine. Talwin C-IV. Phenobarbital. Luminal C-IV. Phentermine. Adipex-P, Suprenza C-IV.

Video: Arena: DEA Schedule IV Will Make Belviq The Obesity

Belviq Uses, Dosage, Side Effects and Recal

Belviq (generic name lorcaserin) is a popular prescription weight-loss drug made by Eisai Inc. to help people experiencing obesity and weight-related health issues curb their hunger. Alarmingly, a U.S. Food and Drug Administration (FDA) safety trial concluded that the drug could increase the risk of several different types of cancer, including. FREE CASE EVALUATION. LIVE CHAT. (800) 555-5555. Belviq is a weight loss drug that is designed to treat obesity. The medication, which was approved by the FDA in 2012, was designed to curb the appetite and give people the feeling of being full. Unfortunately, many people that took Belviq experienced serious side effects

Contact Goza & Honnold, LLC. If you took Belviq or Belviq XR for weight loss and have since been diagnosed with cancer, contact Goza & Honnold today by calling (913) 451-3433. We offer free case consultations with our experienced defective drug attorneys, and we can help you determine if you are eligible to file a lawsuit against the drug. In the trial, the Belviq group had 662 patients who were diagnosed with 520 cancers, and the 423 placebo patients were diagnosed with 470 cancers. If a patient was taking Belviq for a long period of time, then they will have a greater risk of developing cancer, according to a report by The Food and Drug Administration (FDA)

Lorcaserin (Belviq) - AbsolutePills offers 24/7 free

Belviq Cancer Lawsuit Attorney. On February 13, 2020, the U.S. Food and Drug Administration (FDA) announced a voluntary recall of the prescription drug Belviq after studies revealed elevated cancer risks among patients taking it. Belviq, manufactured by Eisai, Inc., is a prescription drug prescribed primarily for overweight and obese patients struggling to lose weight These drugs have less potential for abuse/dependence than schedule II/III drugs. have a low potential for abuse relative to the drugs or other substances in Schedule III. Abuse of Schedule IV drugs may lead to limited physical dependence or psychological dependence compared with Schedule III drugs. Examples include Valium® and Xanax® Call (973) 947-4670 or fill out our online contact form to schedule a free consultation about your case. We have an office conveniently located at 189 Franklin Avenue, Suite 1 Nutley, NJ 07110, as well as a satellite office in Hamilton, NJ Albiglutide: (Moderate) In general, weight reduction may increase the risk of hypoglycemia in patients with type 2 diabetes mellitus treated with antidiabetic agents, such as insulin and/or insulin secretagogues (e.g., sulfonylureas). In clinical trials, lorcaserin use was associated with reports of hypoglycemia BELVIQ ® is an FDA-approved prescription weight loss medication that, when used in combination with diet and exercise, can help some overweight (Body Mass Index [BMI] ≥27 kg/m²) adults with a weight-related medical problem, or obese (BMI ≥30 kg/m²) adults, lose weight and keep it off.. How Does BELVIQ ® Work?. BELVIQ ® may help you to feel satisfied with less food by targeting the.

Belviq - FDA prescribing information, side effects and uses

(a) Refills of Qsymia(TM) and Belviq are allowed after an initial Qsymia(TM) or Belviq prescription and one follow up visit for an in-person re-evaluation. For Qsymia and Belviq, five (5) refills are allowed. The five (5) refills shall not extend past a period of six (6) months from the date of issue of the original prescription Belviq will require a prescription from a doctor and is designed to be used with a low-calorie diet and exercise program. Some of the symptoms that may lead a doctor to prescribe Belviq are being an adult with a BMI greater than 30

Belviq has been requested to be put in the fourth schedule. Eisai, who will market Belviq in the US, will decide on the drug's launch only after the DEA gives its verdict on the matter Belviq can be given to a person with or without food. 2. Distribution. Belviq distributes itself to the central nervous system and cerebrospinal fluid in humans. Belviq hydrochloride is bound to human plasma proteins. 3. Metabolism. Multiple enzymatic pathways are used for metabolizing belviq in the liver Buying Belviq Online Safely. The most common reasons to buy Belviq without a prescription are: to relieve stress or to overcome a difficult crisis or problem such as pregnancy, illness, an old age. If you buy Belviq without a prescription, it is generally safe to use it with caution BELVIQ: MILD HEADACHES, DRY MOUTH, Harris is nobody's idea of obese, but her relentless schedule had, over time, added about 30 pounds to her formerly petite 5'6, 125-pound frame. I saw a.

Eisai announced the launch of Believe Everyday Support, a free online patient support and savings support for patients taking Belviq (lorcaserin HCl) Checkwith your insurance company on your coverage.Belviq is a Schedule IV controlled substance and needs tobe prescribed by a licensed doctor for a valid medicalreason.1(800)W8MD-007 NE Philadelphia, And King Of Prussia in PA New York City Stamford, CT 15 Belviq is a brand name for a weight-loss drug called Locaserin manufactured by Eisai Inc. The drug is meant to reduce a person's appetite by activating serotonin in a part of the brain. The drug makes users feel full so they do not feel hungry. Call today to schedule your free consultation

Belviq, also known as lorcaserin and which additionally comes in an extended-release form, was produced by the company Eisai Incorporated. Belviq is a drug prescribed for weight loss, and functions as an appetite suppressant by activating a particular serotonin receptor found in the brain's hypothalamus National. This undated image provided by Eisai in August 2018 shows the company's Belviq medication. (Eisai via AP) The maker of a weight loss drug pulled it from the market Thursday at the. WOODCLIFF LAKE, N.J., May 7, 2013 /PRNewswire/ -- Eisai Inc. announced today that the U.S. Drug Enforcement Administration (DEA) has placed BELVIQ (pronounced BEL-VEEK) into Schedule IV of the Controlled Substances Act. This information is expected to be published in the Federal Register on May 8, with an effective date of June 7, 2013 The drug's launch was delayed for months by logistical hurdles, including classification by the Drug Enforcement Administration. According to the drug's label, Belviq will be classified as a Schedule IV controlled substance, which means it has a low potential for abuse Arena Pharmaceuticals Inc. recently announced that the US Drug Enforcement Administration (:DEA) has assigned its obesity drug Belviq into Schedule IV of the Controlled Substances Act.The company.

Introduction. Arcadier, Biggie and Wood, PLLC is an established AV rated law firm with experienced attorneys in evaluating claims from individuals who were diagnosed with cancer after taking Belviq, Belviq XR, or another brand of lorcaserin Belviq was a 10 mg tablet that you took twice a day, while Belviq XR was an extended-release drug that you took only once a day. These drugs were approved for use in adult patients with a body mass index (BMI) of 30 or more or any adult with a BMI of 27 who also had other conditions, such as high blood pressure, Type 2 diabetes, or high. a Results are from a 56-week trial of 3,731 adults with body mass index (BMI) of 27-29.9 with at least 1 weight-related condition, or BMI of at least 30 not including adults with type 2 diabetes. In this study, 2,487 patients received Saxenda ® and 1,244 received placebo. Both groups also received a reduced calorie diet and physical activity counseling

Our extensive experience in product liability and personal injury law provides us with the tools you need to face Belviq's manufacturers in the courtroom. Contact Estey & Bomberger, LLP today to schedule a free consultation with one of our San Diego Belviq lawyers controlled drug substance Any drug or therapeutic agent-commonly understood to include narcotics, with a potential for abuse or addiction, which is held under strict governmental control, as delineated by the Comprehensive Drug Abuse Prevention & Control Act passed in 1970 Controlled drug substances Schedule I drugs High abuse potential, no accepted. Belviq, also known as lorcaserin, is a commonly prescribed weight loss and control supplement prescribed to patients struggling with high blood pressure and diabetes. In February of 2020, the Food and Drug Administration (FDA) announced that all Belviq products be removed from stores' shelves as studies had shown a potential cancer link Belviq works by stimulating certain receptors in the brain to reduce appetite. In other words, it makes people feel less hungry than they otherwise would. Belviq cases, it's reasonable to expect to begin receiving funds within six to eight weeks, though, again, a specific schedule may be established in the settlement agreement

Helping The DEA With Arena Pharmaceuticals' Belviq's Final

WOODCLIFF LAKE, N.J., May 7, 2013 /PRNewswire/ -- Eisai Inc. announced today that the U.S. Drug Enforcement Administration (DEA) has placed BELVIQ (pronounced BEL-VEEK) into Schedule IV of the. BELVIQ was launched in the United States in June 2013 after being given a schedule rating from the U.S. Drug Enforcement Administration (DEA). Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd., possesses exclusive marketing and supply rights for BELVIQ in the United States, Mexico, Brazil, Canada and 17 other countries in the Americas region The DEA is taking its sweet time determining the abuse potential for Arena's weight-loss pill

Lorcaserin - Belviq Weight Loss Medicine - Medicine

Lorcaserin - Wikipedi

BELVIQ will be available in the United States only after Drug Enforcement Agency (DEA) scheduling is effective. The DEA has published a notice in the Federal Register recommending that BELVIQ be classified as a Schedule IV controlled substance, and BELVIQ is currently awaiting final scheduling designation. IMPORTANT SAFETY INFORMATION. Eisai Co. will withdraw its weight loss drug Belviq after the US Food and Drug Administration said clinical trials showed an increased incidence of cancer among users, the company said

Possible increased cancer risk with Belviq, Belviq XR

Our experienced Belviq lawsuit attorneys are skilled in bringing successful drug-related lawsuits. We will carefully examine your case and advise you about your options. Belviq and Belviq XR, which is the extended-release form of the medication, are brand names for the generic drug lorcaserin Belviq/Belviq XR (lorcaserin) is a drug that was used as a long-term weight-loss treatment for obese individuals. Belviq XR was the extended-release version of the original drug. It was manufactured, marketed, and distributed by Eisai Inc in the United States. The FDA approved Belviq in 2012 Belviq Cancer Lawsuit. Belviq is a popular prescription weight loss drug that is designed to treat obesity. It is sometimes used by people with diabetes to deal with some of the weight gain associated with that illness. However, Belviq has been reported to have some serious side effects

What is Belviq? - GoodR

Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ® (lorcaserin HCl) for Chronic Weight Management -- Arena to Receive $65 Million in Milestone Payments from Eisai - Qsymia is a schedule IV-controlled substance, so it is NOT available without a prescription. Where to Fill Your Prescription. Qsymia is available from most major pharmacies in the United States, including certified mail-order pharmacies. Due to its drug schedule, these capsules are not available from all online pharmacies

Attorney Thomas Tona | TonaLaw

Belviq Cancer Lawsuits Belviq Recall Belviq Injury

An extended-release version called Belviq XR also is being pulled from the market. In testing before Belviq was approved, nearly half of participants given Belviq lost at least 5% of their weight. The dosing schedule is designed to reduce the likelihood of gastrointestinal symptoms. Tell your health care provider if you have any side effect that bothers you or that does not go away. Learn more about Saxenda ®, including possible side effects, in the Medication Guide According to IQVIA, in 2018 Belviq brought in $8.2 million in the United States, making it the top performer in its market for that year. From April 1, 2019 to December 31, 2019, Eisai reported $42 million in sales for Belviq and Belviq XR throughout the world. Eisai's revenues from 2019 reflected a 14% increase from the previous year Belviq Recall Cancer Lawsuit. The Food and Drug Administration (FDA) has recommended a recall of all lots of Belviq and Belviq XR from the U.S. market after a clinical study found an increase in the occurrence of cancer among users. The cancers linked to Belviq include lung cancer, pancreatic cancer, and colorectal cancer